Showing results (141-150 of 10,436) with videos related to

Sort By:
Pageof 1,044
AIDS (London, England)|August 1, 1997
Homozygous delta 32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patientC Balotta, P Bagnarelli, M Violin, et al.
AIDS (London, England)|August 1, 1997
Induction of apoptosis by primary HIV-1 isolates correlates with productive infection in peripheral blood mononuclear cellsY J Zhang, B Fadeel, V Hodara, et al.
AIDS (London, England)|June 10, 1998
Induction-maintenance antiretroviral therapy: proof of conceptD B Hall, J G Montaner, P Reiss, et al.
AIDS (London, England)|June 10, 1998
Discrepant responses to triple combination antiretroviral therapy in advanced HIV diseaseC Piketty, P Castiel, L Belec, et al.
AIDS (London, England)|June 10, 1998
Incubation period of HIV-1 in perinatally infected children. New York City Perinatal HIV Transmission Collaborative Study GroupV Pliner, J Weedon, P A Thomas, et al.
AIDS (London, England)|June 10, 1998
Modelling the spread of HIV in social networks of injecting drug usersM Kretzschmar, L G Wiessing
AIDS (London, England)|June 20, 1998
Altered natural history of AIDS-related opportunistic infections in the era of potent combination antiretroviral therapyM A Jacobson, M French
AIDS (London, England)|April 28, 2015
Reduction of soluble CD163, substance P, programmed death 1 and inflammatory markers: phase 1B trial of aprepitant in HIV-1-infected adultsPablo Tebas, Sergei Spitsin, Jeffrey S Barrett, et al.
AIDS (London, England)|April 28, 2015
The causal effect of opioid substitution treatment on HAART medication refill adherenceBohdan Nosyk, Jeong E Min, Guillaume Colley, et al.
AIDS (London, England)|December 31, 1997
Increased frequency of CCR-5 delta 32 heterozygotes among long-term non-progressors with HIV-1 infection. The Australian Long-Term Non-Progressor Study GroupG J Stewart, L J Ashton, R A Biti, et al.
Pageof 1,044